» Articles » PMID: 938029

In Vitro Comparison of Cefoxitin, Cefamandole, Cephalexin, and Cephalothin

Overview
Specialty Pharmacology
Date 1976 Jun 1
PMID 938029
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

The in vitro effect of cefoxitin, cefamandole, cephalexin, and cephalothin was tested against 645 strains of bacteria recently isolated from clinical sources. Against gram-positive organisms cephalothin and cefamandole were the most effective, generally being three- to fourfold more active than cephalexin or cefoxitin. Enterococci were not inhibited by less than 25 mug of any of the antibiotics per ml. Against Enterobacteriaceae, cefoxitin and cefamandole were the most active. An exception was the Enterobacter strains, against which cefoxitin was the least effective. None of the Pseudomonas aeruginosa strains were susceptible to 100 mug of any of the cephalosporins per ml. Cefamandole was the most active agent against Neisseria meningitidis and Neisseria gonorrhoeae. It was also the most effective agent against Haemophilus influenzae, even when taking into account a threefold inoculum effect.

Citing Articles

Inoculum effect of β-lactam antibiotics.

Lenhard J, Bulman Z J Antimicrob Chemother. 2019; 74(10):2825-2843.

PMID: 31170287 PMC: 6753498. DOI: 10.1093/jac/dkz226.


Cefoxitin concentrations in the cerebrospinal fluids of patients with meningitis.

Humbert G, Leroy A, Rogez J, Cherubin C Antimicrob Agents Chemother. 1980; 17(4):675-8.

PMID: 7396457 PMC: 283851. DOI: 10.1128/AAC.17.4.675.


Clinical and pharmacokinetic evaluation of parental cefoxitin in infants and children.

Feldman W, Moffitt S, Sprow N Antimicrob Agents Chemother. 1980; 17(4):669-74.

PMID: 7396456 PMC: 283850. DOI: 10.1128/AAC.17.4.669.


The cephalosporins: activity and clinical use.

Weinstein A Drugs. 1980; 20(2):137-54.

PMID: 6995096 DOI: 10.2165/00003495-198020020-00007.


Limited in vitro activity of cefamandole against 100 beta-lactamase- and non-beta-lactamase-producing Haemophilus influenzae strains: comparison of moxalactam, chloramphenicol, and ampicillin.

Bergeron M, Claveau S, Simard P Antimicrob Agents Chemother. 1981; 19(1):101-5.

PMID: 6454379 PMC: 181364. DOI: 10.1128/AAC.19.1.101.


References
1.
Moellering Jr R, Dray M, KUNZ L . Susceptibility of clinical isolates of bacteria to cefoxitin and cephalothin. Antimicrob Agents Chemother. 1974; 6(3):320-3. PMC: 444644. DOI: 10.1128/AAC.6.3.320. View

2.
Brumfitt W, Kosmidis J, Hamilton-Miller J, Gilchrist J . Cefoxitin and cephalothin: antimicrobial activity, human pharmacokinetics, and toxicology. Antimicrob Agents Chemother. 1974; 6(3):290-9. PMC: 444639. DOI: 10.1128/AAC.6.3.290. View

3.
Neu H . Cefamandole, a cephalosporin antibiotic with an unusually wide spectrum of activity. Antimicrob Agents Chemother. 1974; 6(2):177-82. PMC: 444624. DOI: 10.1128/AAC.6.2.177. View

4.
Neu H . Cefoxitin, a semisynthetic cephamycin antibiotic: antibacterial spectrum and resistance to hydrolysis by gram-negative beta-lactamases. Antimicrob Agents Chemother. 1974; 6(2):170-6. PMC: 444623. DOI: 10.1128/AAC.6.2.170. View

5.
Onishi H, DAOUST D, Zimmerman S, HENDLIN D, Stapley E . Cefoxitin, a semisynthetic cephamycin antibiotic: resistance to beta-lactamase inactivation. Antimicrob Agents Chemother. 1974; 5(1):38-48. PMC: 428916. DOI: 10.1128/AAC.5.1.38. View